HK1076114A1 - Novel peptide having angiotensin convertase inhibitory effect - Google Patents

Novel peptide having angiotensin convertase inhibitory effect

Info

Publication number
HK1076114A1
HK1076114A1 HK05108163A HK05108163A HK1076114A1 HK 1076114 A1 HK1076114 A1 HK 1076114A1 HK 05108163 A HK05108163 A HK 05108163A HK 05108163 A HK05108163 A HK 05108163A HK 1076114 A1 HK1076114 A1 HK 1076114A1
Authority
HK
Hong Kong
Prior art keywords
inhibitory effect
novel peptide
angiotensin convertase
convertase inhibitory
angiotensin
Prior art date
Application number
HK05108163A
Other languages
English (en)
Inventor
Yoshitaka Tamura
Hiroshi Miyakawa
Akio Yamada
Hitoshi Saito
Yasushi Kawaguchi
Hiroshi Ochi
Tomoko Ide
Eri Inoue
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19167543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1076114(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of HK1076114A1 publication Critical patent/HK1076114A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
HK05108163A 2001-11-21 2005-09-16 Novel peptide having angiotensin convertase inhibitory effect HK1076114A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001355923 2001-11-21
PCT/JP2002/012197 WO2003044044A1 (fr) 2001-11-21 2002-11-21 Nouveau peptide exerçant un effet inhibiteur d'angiotensine convertase

Publications (1)

Publication Number Publication Date
HK1076114A1 true HK1076114A1 (en) 2006-01-06

Family

ID=19167543

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05108163A HK1076114A1 (en) 2001-11-21 2005-09-16 Novel peptide having angiotensin convertase inhibitory effect

Country Status (19)

Country Link
US (1) US7022676B2 (xx)
EP (1) EP1457498B9 (xx)
JP (1) JP3816921B2 (xx)
KR (1) KR100615844B1 (xx)
CN (1) CN1240711C (xx)
AT (1) ATE353336T1 (xx)
AU (1) AU2002366037B2 (xx)
BR (1) BR0214299A (xx)
CA (1) CA2468039C (xx)
CY (1) CY1106557T1 (xx)
DE (1) DE60218064T2 (xx)
DK (1) DK1457498T3 (xx)
ES (1) ES2281567T3 (xx)
HK (1) HK1076114A1 (xx)
MX (1) MXPA04004805A (xx)
NO (1) NO328611B1 (xx)
NZ (1) NZ533544A (xx)
PT (1) PT1457498E (xx)
WO (1) WO2003044044A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA87278C2 (ru) 2003-08-01 2009-07-10 Калпис Ко., Лтд. Пептиды, которые биологически не разлагаются; ингибитор ангиотензинпревращающего фермента, лекарственное средство и функциональный пищевой продукт
CN1894273B (zh) * 2003-12-01 2011-01-12 明治乳业株式会社 血管紧张素转化酶抑制肽
CN102304169B (zh) * 2011-08-05 2013-03-20 成都中医药大学 降血压多肽及其用途
CN102276690B (zh) * 2011-08-05 2013-03-20 成都中医药大学 降血压功能性多肽及其用途
JP5926363B2 (ja) * 2012-02-22 2016-05-25 森永乳業株式会社 ジペプチジルペプチダーゼ−ｉｖ阻害剤
EP2824110A4 (en) 2012-03-09 2015-12-30 Morinaga Milk Industry Co Ltd DIPEPTIDYL PEPTIDASE-IV INHIBITOR
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
JP6344796B2 (ja) * 2014-09-30 2018-06-20 森永乳業株式会社 高齢者用アルツハイマー型認知症改善剤
JP2018057346A (ja) * 2016-10-07 2018-04-12 森永乳業株式会社 カゼイン酵素処理物及びその製造方法
CN107337710A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物
CN111093685A (zh) * 2017-09-19 2020-05-01 森永乳业株式会社 用于促进能量消耗的组合物
US20210000129A1 (en) * 2018-02-16 2021-01-07 Morinaga Milk Industry Co., Ltd. Composition for lowering blood pressure and/or reducing neutral fats
JP6589011B2 (ja) * 2018-05-17 2019-10-09 森永乳業株式会社 脳機能障害改善用経口組成物
CN113321719B (zh) * 2021-05-20 2022-03-18 澳优乳业（中国）有限公司 一种寡肽及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07313185A (ja) * 1992-08-20 1995-12-05 Marino Forum 21 ぺプチドの製造方法
JP3040389B2 (ja) * 1999-01-18 2000-05-15 日本合成化学工業株式会社 ペプチドの製造法

Also Published As

Publication number Publication date
MXPA04004805A (es) 2004-08-11
PT1457498E (pt) 2007-05-31
DK1457498T3 (da) 2007-06-04
EP1457498A4 (en) 2005-10-19
DE60218064D1 (de) 2007-03-22
ES2281567T3 (es) 2007-10-01
EP1457498B1 (en) 2007-02-07
NO328611B1 (no) 2010-03-29
KR20050044541A (ko) 2005-05-12
KR100615844B1 (ko) 2006-08-25
CA2468039A1 (en) 2003-05-30
US7022676B2 (en) 2006-04-04
CY1106557T1 (el) 2012-01-25
JPWO2003044044A1 (ja) 2005-03-10
EP1457498A1 (en) 2004-09-15
DE60218064T2 (de) 2007-11-15
CN1612892A (zh) 2005-05-04
US20050004041A1 (en) 2005-01-06
CN1240711C (zh) 2006-02-08
AU2002366037B2 (en) 2005-11-03
EP1457498B9 (en) 2009-09-02
WO2003044044A1 (fr) 2003-05-30
AU2002366037A1 (en) 2003-06-10
NZ533544A (en) 2005-02-25
JP3816921B2 (ja) 2006-08-30
CA2468039C (en) 2011-01-04
ATE353336T1 (de) 2007-02-15
NO20042601L (no) 2004-08-18
BR0214299A (pt) 2004-12-14

Similar Documents

Publication Publication Date Title
HK1076114A1 (en) Novel peptide having angiotensin convertase inhibitory effect
ATE310009T1 (de) Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen
MXPA03006438A (es) Uso novedoso de una clase peptidica de compuesto para tratar la alodinia u otros tipos diferentes de dolor cronico o fantasmal.
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
AU2002310156A1 (en) 1,4-disubstituted benzo-fused cycloalkyl urea compounds
HUP0203130A2 (hu) Hexahidrofuro[2,3-b]furán-3-il-N-{3-(1,3-benzodioxol-5-il-szulfonil)-(izobutil)-amino-1-benzil-2-(hidroxi-propil)}-karbamát mint retrovírus-proteáz-gátló
HK1062885A1 (en) Spiropyrazole compounds
AU2001242136A1 (en) Amino acid derivatives as hiv aspartyl protease inhibitors
SG144736A1 (en) Synthesis of temozolomide and analogs
MXPA03009602A (es) Analogos de nociceptina.
AU2001272504A1 (en) 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof
SG143062A1 (en) Synthesis of temozolomide and analogs
SE0101082D0 (sv) Novel use
WO2002100895A3 (de) Antimikrobiell wirkendes peptid
IT1317722B1 (it) Procedimento per la produzione di gas di sintesi.
GEP20063936B (en) New anhydrous crystalline forms of gabapentin
EP1406614A4 (en) CARVEDILOLPOLYMORPH
ATE405668T1 (de) Exopolysaccharidproduktion
ITRM20030091A1 (it) Procedimento per la produzione di una connessione a tenuta di umidita'.
WO2002061074A1 (fr) Nouvelle proteine et adn la comprenant
MXPA04003478A (es) Sintesis de (4-bromofenil)(4-piperidil)metanona-(z)-o-etiloxima y sales.
DE50100533D1 (de) Herstellung von 2-ethyl-3-methyl-1,4-diazin
AP1432A (en) Monohydrate of Cis-Lithium-Cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate.
WO2001064861A3 (de) Phosphoribosyl-pyrophosphat synthetase 1 als herbizides target
ITMI20020542A1 (it) Procedimento per la sintesi di idroperossido di cumene

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141121